Hello, Fool! | Login | Signup | My Fool
Jul 20, 2008 12:48 PM ET | Site Changes | Help
Search: Tickers Company Names Players
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
Jeffreyw (89.61) Submitted: 4/15/08 6:00 PM : Start Price: $51.00 CELG Score: 50.08
Promising therapies and possible takeover target.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK